These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12203050)

  • 1. Effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in mice.
    Ukai M; Suzuki M; Mamiya T
    J Neural Transm (Vienna); 2002 Sep; 109(9):1221-5. PubMed ID: 12203050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse.
    Narita M; Khotib J; Mizoguchi H; Suzuki M; Ozaki S; Yajima Y; Tseng LF; Suzuki T
    Eur J Neurosci; 2003 Nov; 18(9):2498-504. PubMed ID: 14622150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL; Nayanar V; Walker JS
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.
    Wang YJ; Rasakham K; Huang P; Chudnovskaya D; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2011 Nov; 339(2):438-50. PubMed ID: 21841040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of dopamine D2 receptor signal transduction in the discriminative stimulus effects of the κ-opioid receptor agonist U-50,488H in rats.
    Mori T; Yoshizawa K; Ueno T; Nishiwaki M; Shimizu N; Shibasaki M; Narita M; Suzuki T
    Behav Pharmacol; 2013 Aug; 24(4):275-81. PubMed ID: 23838963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells.
    Li J; Li JG; Chen C; Zhang F; Liu-Chen LY
    Mol Pharmacol; 2002 Jan; 61(1):73-84. PubMed ID: 11752208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes.
    Zhou JJ; Bian JS; Pei JM; Wu S; Li HY; Wong TM
    Br J Pharmacol; 2002 Apr; 135(7):1675-84. PubMed ID: 11934807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
    Skoubis PD; Matthes HW; Walwyn WM; Kieffer BL; Maidment NT
    Neuroscience; 2001; 106(4):757-63. PubMed ID: 11682161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.
    Ukai M; Kameyama T
    Brain Res; 1985 Jul; 337(2):352-6. PubMed ID: 2992682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonopioid receptor-mediated effects of U-50,488H on [Ca(2+)]i and extracellular dopamine in PC12 cells.
    Chudapongse N; Kim SY; Sasaki K; Kramer RE; Ho IK
    J Neurosci Res; 2003 Nov; 74(4):598-604. PubMed ID: 14598304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy.
    Hiramatsu M; Hoshino T
    Brain Res; 2004 Dec; 1030(2):247-55. PubMed ID: 15571673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization.
    Chen C; Chiu YT; Wu W; Huang P; Mann A; Schulz S; Liu-Chen LY
    Biochem J; 2016 Feb; 473(4):497-508. PubMed ID: 26635353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria.
    Raffa RB; Baron DA; Tallarida RJ
    Eur J Pharmacol; 2006 Jul; 540(1-3):200-1. PubMed ID: 16737694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
    Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
    Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. κ Opioid receptor activation in different brain regions differentially modulates anxiety-related behaviors in mice.
    Wang YJ; Hang A; Lu YC; Long Y; Zan GY; Li XP; Wang Q; Zhao ZX; He L; Chi ZQ; Liu JG
    Neuropharmacology; 2016 Nov; 110(Pt A):92-101. PubMed ID: 27106167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa-opioid receptor stimulation inhibits growth of neonatal rat ventricular myocytes.
    Wang G; Wang H; Yang Y; Wong TM
    Eur J Pharmacol; 2004 Sep; 498(1-3):53-8. PubMed ID: 15363975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory role of ginsenosides injected intrathecally or intracerebroventricularly in the production of antinociception induced by kappa-opioid receptor agonist administered intracerebroventricularly in the mouse.
    Suh HW; Song DK; Huh SO; Kim YH
    Planta Med; 2000 Jun; 66(5):412-7. PubMed ID: 10909259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsive effects of kappa-opioid receptor modulation in an animal model of ethanol withdrawal.
    Beadles-Bohling AS; Wiren KM
    Genes Brain Behav; 2006 Aug; 5(6):483-96. PubMed ID: 16923153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p38 mitogen-activated protein kinase activation in amygdala mediates κ opioid receptor agonist U50,488H-induced conditioned place aversion.
    Zan GY; Wang Q; Wang YJ; Chen JC; Wu X; Yang CH; Chai JR; Li M; Liu Y; Hu XW; Shu XH; Liu JG
    Neuroscience; 2016 Apr; 320():122-8. PubMed ID: 26826330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.